Sale!

Ophthalmologic Drug Guide (Paperback)  | Released: 01-Nov-06

By: Rhee,D.J., Colby,K.A. (Author)   Publisher: Springer

25.00% Off Original price was: 695.00$.Current price is: 521.00$.

You save 174.00$
Ophthalmology has long been considered a surgical area because so many disorders/diseases are treated surgically rather than medically. In the past ten years, however, there have been considerable therapeutic breakthroughs in non-surgical treatments. For instance, anti-glaucoma agents have becoming increasingly effective. This edition will include a new chapter for retinal... Read More

In stock

Buy Now
Ships within 1-2 Business Days

100% Orginal Books

Easy Replacement

Certified product

Secure Checkout

On time delivery

Author:

Rhee,D.J., Colby,K.A.

Publisher Name:

Springer

Language:

English

Binding:

(Paperback)

About The Book
Ophthalmology has long been considered a surgical area because so many disorders/diseases are treated surgically rather than medically. In the past ten years, however, there have been considerable therapeutic breakthroughs in non-surgical treatments. For instance, anti-glaucoma agents have becoming increasingly effective. This edition will include a new chapter for retinal disease. There are now several pharmaceutical agents being used to treat these diseases. Specifically, age-related macular degeneration has many new products a" macugen, lucentis, etc. a" and intraocular infections are primarily treated with intravitreal medications. Additionally, the anti-allergy and dry eye markets have grown tremendously in the last 2-3 years (endura, restasis, xibrom, etc).This book contains all inclusive formulary for ocular prescription medications and includes new agents in retinal disease. Ophthalmology has long been considered a surgical area because so many disorders/diseases are treated surgically rather than medically. In the past ten years, however, there have been considerable therapeutic breakthroughs in non-surgical treatments. For instance, anti-glaucoma agents have become increasingly effective. This edition includes a new chapter for retinal disease. There are now several pharmaceutical agents being used to treat these diseases. Specifically, age-related macular degeneration has many new products.